Skip to content

ArtVentive Medical Group, Inc.: 10-Q filed 2015-11-16

What ArtVentive Medical Group, Inc. reported in its quarterly report filed 2015-11-16 (fiscal Q2 2015): 25 published measures, 61 facts as tagged in accession 0001056520-15-000176.

This filing

Form
10-Q (quarterly report)
Filed
2015-11-16
Fiscal period
fiscal Q2 2015
Accession
0001056520-15-000176 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ArtVentive Medical Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-06-30591,109USD
At 2014-12-31188,971USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-06-30-384,602USD
At 2014-12-31-1,575,726USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-06-30208,527USD
At 2014-12-31104,030USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-01-01 to 2015-06-30-1,853,383USD181
2014-01-01 to 2014-06-30-3,312,462USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-06-30-5,849USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-04-01 to 2015-06-3093,998USD91
2015-01-01 to 2015-06-30158,185USD181
2014-04-01 to 2014-06-3025,470USD91
2014-01-01 to 2014-06-3035,635USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2015-01-01 to 2015-06-301,950,000USD181
2014-01-01 to 2014-06-302,700,000USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2015-01-01 to 2015-06-30-5,849USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-06-30-16,368,597USD
At 2014-12-31-14,515,214USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-06-3016,110USD
At 2014-12-3112,486USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-965,202USD91
2015-01-01 to 2015-06-30-1,853,385USD181
2014-04-01 to 2014-06-30-1,556,111USD91
2014-01-01 to 2014-06-30-3,313,080USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-06-30477,595USD
At 2014-12-31151,478USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-06-30475,711USD
At 2014-12-311,264,697USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-06-30475,650USD
At 2014-12-31221,397USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2015-04-01 to 2015-06-30639,771USD91
2015-01-01 to 2015-06-301,225,098USD181
2014-04-01 to 2014-06-30185,423USD91
2014-01-01 to 2014-06-301,652,099USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-04-01 to 2015-06-30324,136USD91
2015-01-01 to 2015-06-30626,062USD181
2014-04-01 to 2014-06-301,369,916USD91
2014-01-01 to 2014-06-301,659,438USD181

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-06-3015,921,578USD
At 2014-12-3112,879,982USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2015-06-30-7,692USD
At 2014-12-31-5,467USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-12-311,043,300USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-965,201USD91
2015-01-01 to 2015-06-30-1,853,383USD181
2014-04-01 to 2014-06-30-1,555,970USD91
2014-01-01 to 2014-06-30-3,312,462USD181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-965,201USD91
2015-01-01 to 2015-06-30-1,853,383USD181
2014-04-01 to 2014-06-30-1,555,970USD91
2014-01-01 to 2014-06-30-3,312,462USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2015-04-01 to 2015-06-301,295USD91
2015-01-01 to 2015-06-302,225USD181
2014-04-01 to 2014-06-30772USD91
2014-01-01 to 2014-06-301,543USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-30-48,544USD181
2014-01-01 to 2014-06-30-9,900USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-30-173,076USD181
2014-01-01 to 2014-06-30-236,576USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-30254,253USD181
2014-01-01 to 2014-06-30-127,820USD181

Inspect the source

Entity
ArtVentive Medical Group, Inc. / CIK 0001405249
Captured
SEC response SHA-256
01b8937f2876d513617b1d921d4a98ec6f536680d197470785bad286f4947f07

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001405249.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))